Skip to main content
Addgene
Showing: 41 - 60 of 298 results

  1. CaMKII-somBiPOLES-mCerulean (AAV Retrograde)

    Viral Prep
    #154948-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from CaMKII-somBiPOLES-mCerulean (#154948). In addition to the viral particles, you will also receive purified CaMKII-somBiPOLES-mCerulean plasmid DNA. CamKII-driven expression of soma-targeted BiPOLES for optogenetic inhibition (blue light) and activation (red light). These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Simon Wiegert
    Article
    Vierock et al Nat Commun. 2021 Jul 26;12(1):4527. doi:
    Promoter
    CaMKIIa(0.4)
    Tags
    mCerulean
    Available since
    Sept. 1, 2021
    Availability
    Academic Institutions and Nonprofits only

  2. hSyn-DIO-somBiPOLES-mCerulean (AAV Retrograde)

    Viral Prep
    #154951-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from hSyn-DIO-somBiPOLES-mCerulean (#154951). In addition to the viral particles, you will also receive purified hSyn-DIO-somBiPOLES-mCerulean plasmid DNA. Synapsin-driven, Cre-dependent expression of soma-targeted BiPOLES for optogenetic inhibition (blue light) and activation (red light). These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Simon Wiegert
    Article
    Vierock et al Nat Commun. 2021 Jul 26;12(1):4527. doi:
    Promoter
    Syn
    Tags
    mCerulean (Cre-dependent)
    Available since
    Sept. 1, 2021
    Availability
    Academic Institutions and Nonprofits only

  3. pAAV CD68-hM4D(Gi)-mCherry (AAV1)

    Viral Prep
    #75033-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV CD68-hM4D(Gi)-mCherry (#75033). In addition to the viral particles, you will also receive purified pAAV CD68-hM4D(Gi)-mCherry plasmid DNA. CD68-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced microglial inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Article
    Grace et al Proc Natl Acad Sci U S A. 2016 Jun 14;11
    Promoter
    CD68
    Tags
    mCherry
    Available since
    March 27, 2019
    Availability
    Academic Institutions and Nonprofits only

  4. pAAV CD68-hM4D(Gi)-mCherry (AAV9)

    Viral Prep
    #75033-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV CD68-hM4D(Gi)-mCherry (#75033). In addition to the viral particles, you will also receive purified pAAV CD68-hM4D(Gi)-mCherry plasmid DNA. CD68-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced microglial inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Article
    Grace et al Proc Natl Acad Sci U S A. 2016 Jun 14;11
    Promoter
    CD68
    Tags
    mCherry
    Available since
    Sept. 27, 2023
    Availability
    Academic Institutions and Nonprofits only

  5. pAAV-S5E2-ChR2-mCherry (AAV9)

    Viral Prep
    #135634-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-S5E2-ChR2-mCherry (#135634). In addition to the viral particles, you will also receive purified pAAV-S5E2-ChR2-mCherry plasmid DNA. Expression of ChR2-mCherry under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Promoter
    Tags
    mCherry
    Available since
    Sept. 15, 2021
    Availability
    Academic Institutions and Nonprofits only

  6. pAAV-S5E2-GCaMP6f (AAV9)

    Viral Prep
    #135632-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-S5E2-GCaMP6f (#135632). In addition to the viral particles, you will also receive purified pAAV-S5E2-GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Promoter
    Tags
    None
    Available since
    Sept. 13, 2021
    Availability
    Academic Institutions and Nonprofits only

  7. pAAV-S5E2-GCaMP6f (AAV1)

    Viral Prep
    #135632-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-S5E2-GCaMP6f (#135632). In addition to the viral particles, you will also receive purified pAAV-S5E2-GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Promoter
    Tags
    None
    Available since
    Nov. 11, 2020
    Availability
    Academic Institutions and Nonprofits only

  8. pAAV-S5E2-ChR2-mCherry (AAV1)

    Viral Prep
    #135634-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-S5E2-ChR2-mCherry (#135634). In addition to the viral particles, you will also receive purified pAAV-S5E2-ChR2-mCherry plasmid DNA. Expression of ChR2-mCherry under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Promoter
    Tags
    mCherry
    Available since
    Nov. 29, 2021
    Availability
    Academic Institutions and Nonprofits only

  9. pLVX-EF1alpha-SARS-CoV-2-orf3a-2xStrep-IRES-Puro (Lentiviral Prep)

    Viral Prep
    #141383-LV
    Purpose
    Ready-to-use Lentiviral Prep particles produced from pLVX-EF1alpha-SARS-CoV-2-orf3a-2xStrep-IRES-Puro (#141383). In addition to the viral particles, you will also receive purified pLVX-EF1alpha-SARS-CoV-2-orf3a-2xStrep-IRES-Puro plasmid DNA. Lentiviral particles carrying SARS-CoV-2-orf3a. This virus is used to make stable cell lines expressing the SARS-CoV-2-orf3a.
    Depositor
    Nevan Krogan
    Article
    Gordon et al Nature. 2020 Jul;583(7816):459-468. doi:
    Promoter
    EF1a
    Tags
    None
    Available since
    May 21, 2020
    Availability
    Academic Institutions and Nonprofits only

  10. pLVX-EF1alpha-SARS-CoV-2-N-2xStrep-IRES-Puro (Lentiviral Prep)

    Viral Prep
    #141391-LV
    Purpose
    Ready-to-use Lentiviral Prep particles produced from pLVX-EF1alpha-SARS-CoV-2-N-2xStrep-IRES-Puro (#141391). In addition to the viral particles, you will also receive purified pLVX-EF1alpha-SARS-CoV-2-N-2xStrep-IRES-Puro plasmid DNA. Lentiviral particles carrying SARS-CoV-2 nucleocapsid (N) protein. This virus is used to make stable cell lines expressing the SARS-CoV-2 nucleocapsid protein.
    Depositor
    Nevan Krogan
    Article
    Gordon et al Nature. 2020 Jul;583(7816):459-468. doi:
    Promoter
    EF1a
    Tags
    None
    Available since
    May 21, 2020
    Availability
    Academic Institutions and Nonprofits only

  11. pLVX-EF1alpha-SARS-CoV-2-M-2xStrep-IRES-Puro (Lentiviral Prep)

    Viral Prep
    #141386-LV
    Purpose
    Ready-to-use Lentiviral Prep particles produced from pLVX-EF1alpha-SARS-CoV-2-M-2xStrep-IRES-Puro (#141386). In addition to the viral particles, you will also receive purified pLVX-EF1alpha-SARS-CoV-2-M-2xStrep-IRES-Puro plasmid DNA. Lentiviral particles carrying SARS-CoV-2 membrane (M) protein. This virus is used to make stable cell lines expressing the SARS-CoV-2 membrane protein.
    Depositor
    Nevan Krogan
    Article
    Gordon et al Nature. 2020 Jul;583(7816):459-468. doi:
    Promoter
    EF1a
    Tags
    None
    Available since
    May 21, 2020
    Availability
    Academic Institutions and Nonprofits only

  12. pLVX-EF1alpha-SARS-CoV-2-E-2xStrep-IRES-Puro (Lentiviral Prep)

    Viral Prep
    #141385-LV
    Purpose
    Ready-to-use Lentiviral Prep particles produced from pLVX-EF1alpha-SARS-CoV-2-E-2xStrep-IRES-Puro (#141385). In addition to the viral particles, you will also receive purified pLVX-EF1alpha-SARS-CoV-2-E-2xStrep-IRES-Puro plasmid DNA. Lentiviral particles carrying SARS-CoV-2-E. This virus is used to make stable cell lines expressing the SARS-CoV-E protein.
    Depositor
    Nevan Krogan
    Article
    Gordon et al Nature. 2020 Jul;583(7816):459-468. doi:
    Promoter
    EF1a
    Tags
    None
    Available since
    July 10, 2020
    Availability
    Academic Institutions and Nonprofits only

  13. pAAV-S5E2-dTom-nlsdTom (AAV1)

    Viral Prep
    #135630-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-S5E2-dTom-nlsdTom (#135630). In addition to the viral particles, you will also receive purified pAAV-S5E2-dTom-nlsdTom plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Promoter
    Tags
    dTomato
    Available since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only

  14. pAAV-S5E2-dTom-nlsdTom (AAV PHP.eB)

    Viral Prep
    #135630-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-S5E2-dTom-nlsdTom (#135630). In addition to the viral particles, you will also receive purified pAAV-S5E2-dTom-nlsdTom plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the E2 regulatory element. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Promoter
    Tags
    dTomato
    Available since
    Oct. 28, 2021
    Availability
    Academic Institutions and Nonprofits only

  15. pAAV-S5E2-ChR2-mCherry (AAV PHP.eB)

    Viral Prep
    #135634-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-S5E2-ChR2-mCherry (#135634). In addition to the viral particles, you will also receive purified pAAV-S5E2-ChR2-mCherry plasmid DNA. Expression of ChR2-mCherry under the control of the E2 regulatory element. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Promoter
    Tags
    mCherry
    Available since
    Oct. 28, 2021
    Availability
    Academic Institutions and Nonprofits only

  16. pAAV-S5E2-GCaMP6f (AAV PHP.eB)

    Viral Prep
    #135632-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-S5E2-GCaMP6f (#135632). In addition to the viral particles, you will also receive purified pAAV-S5E2-GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the E2 regulatory element. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Promoter
    Tags
    None
    Available since
    Sept. 13, 2021
    Availability
    Academic Institutions and Nonprofits only

  17. pAAV-S5E2-GFP-fGFP (AAV9)

    Viral Prep
    #135631-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-S5E2-GFP-fGFP (#135631). In addition to the viral particles, you will also receive purified pAAV-S5E2-GFP-fGFP plasmid DNA. Bicistronic expression of GFP and membrane-targeted GFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Promoter
    Tags
    EGFP
    Available since
    Sept. 27, 2023
    Availability
    Academic Institutions and Nonprofits only

  18. pAAV-S5E2-dTom-nlsdTom (AAV9)

    Viral Prep
    #135630-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-S5E2-dTom-nlsdTom (#135630). In addition to the viral particles, you will also receive purified pAAV-S5E2-dTom-nlsdTom plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Promoter
    Tags
    dTomato
    Available since
    Nov. 29, 2021
    Availability
    Academic Institutions and Nonprofits only

  19. pAAV-S5E2-GFP-fGFP (AAV1)

    Viral Prep
    #135631-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-S5E2-GFP-fGFP (#135631). In addition to the viral particles, you will also receive purified pAAV-S5E2-GFP-fGFP plasmid DNA. Bicistronic expression of GFP and membrane-targeted GFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Promoter
    Tags
    EGFP
    Available since
    Sept. 15, 2021
    Availability
    Academic Institutions and Nonprofits only

  20. pAAV-S5E2-Gq-P2A-dTomato (AAV9)

    Viral Prep
    #135635-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-S5E2-Gq-P2A-dTomato (#135635). In addition to the viral particles, you will also receive purified pAAV-S5E2-Gq-P2A-dTomato plasmid DNA. Expression of Gq-DREADD and dTomato (physically separate) under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Promoter
    Tags
    dTomato (physically separate, not a fusion protein)
    Available since
    Aug. 27, 2021
    Availability
    Academic Institutions and Nonprofits only
Showing: 41 - 60 of 298 results